Please use this identifier to cite or link to this item:
http://hdl.handle.net/1893/26414
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dimeo, Paul | en_UK |
dc.contributor.author | Moller, Verner | en_UK |
dc.date.accessioned | 2017-12-21T04:36:16Z | - |
dc.date.available | 2017-12-21T04:36:16Z | - |
dc.date.issued | 2017-12-18 | en_UK |
dc.identifier.uri | http://hdl.handle.net/1893/26414 | - |
dc.description.abstract | First paragraph: Four-time Tour de France winnerChris Froome’spositive test for high levels of the asthma drugsalbutamolin September during the Vuelta a Espana race has prompted much debate on the rules surrounding medicines in sport. In essence, some drugs are not allowed, and others are allowed up to a threshold level under aTherapeutic Use Exemption(TUE). This creates problems in establishing the threshold level and around accidental over-use, but also opens the door to unethical behaviour. | en_UK |
dc.language.iso | en | en_UK |
dc.publisher | The Conversation Trust | en_UK |
dc.relation | Dimeo P & Moller V (2017) Elite sport: time to scrap the therapeutic exemption system of banned medicines. The Conversation. 18.12.2017. https://theconversation.com/elite-sport-time-to-scrap-the-therapeutic-exemption-system-of-banned-medicines-89252 | en_UK |
dc.rights | The Conversation uses a Creative Commons Attribution NoDerivatives licence. You can republish their articles for free, online or in print. Licence information is available at: http://creativecommons.org/licenses/by-nd/4.0/ | en_UK |
dc.rights.uri | http://creativecommons.org/licenses/by-nd/4.0/ | en_UK |
dc.title | Elite sport: time to scrap the therapeutic exemption system of banned medicines | en_UK |
dc.type | Newspaper/Magazine Article | en_UK |
dc.citation.issn | No ISSN | en_UK |
dc.citation.publicationstatus | Published | en_UK |
dc.type.status | VoR - Version of Record | en_UK |
dc.identifier.url | https://theconversation.com/elite-sport-time-to-scrap-the-therapeutic-exemption-system-of-banned-medicines-89252 | en_UK |
dc.publisher.address | London | en_UK |
dc.contributor.affiliation | Sport | en_UK |
dc.contributor.affiliation | Aarhus University | en_UK |
dc.identifier.wtid | 1020864 | en_UK |
dc.contributor.orcid | 0000-0002-4219-7687 | en_UK |
dcterms.dateAccepted | 2017-12-18 | en_UK |
dc.date.filedepositdate | 2017-12-20 | en_UK |
rioxxterms.type | Other | en_UK |
rioxxterms.version | VoR | en_UK |
local.rioxx.author | Dimeo, Paul|0000-0002-4219-7687 | en_UK |
local.rioxx.author | Moller, Verner| | en_UK |
local.rioxx.project | Internal Project|University of Stirling|https://isni.org/isni/0000000122484331 | en_UK |
local.rioxx.freetoreaddate | 2017-12-20 | en_UK |
local.rioxx.licence | http://creativecommons.org/licenses/by-nd/4.0/|2017-12-20| | en_UK |
local.rioxx.filename | Dimeo-Conversation-2017.pdf | en_UK |
local.rioxx.filecount | 1 | en_UK |
local.rioxx.source | No ISSN | en_UK |
Appears in Collections: | Faculty of Health Sciences and Sport Newspaper/Magazine Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Dimeo-Conversation-2017.pdf | Fulltext - Published Version | 2.32 MB | Adobe PDF | View/Open |
This item is protected by original copyright |
A file in this item is licensed under a Creative Commons License
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/
If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.